2-hydroxyglutarate rides the cancer-immunity cycle.

Foskolou, Iosifina P; Bunse, Lukas; Van den Bossche, Jan

Foskolou, Iosifina P; Bunse, Lukas; Van den Bossche, Jan.

Afiliación

Foskolou IP; Department of Hematopoiesis, Sanquin Research and Department of Hematology University Medical Center, University of Amsterdam, the Netherlands.
Bunse L; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neurology, MCTN, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim Germany.
Van den Bossche J; Department of Molecular Cell Biology and Immunology, Amsterdam Cardiovascular Sciences, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam Institute for Infection and Immunity, Cancer Centre Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Electronic address: j.vandenbossche@amsterdamumc.nl.

Curr Opin Biotechnol ; 83: 102976, 2023 10.

Article en En | MEDLINE | ID: mdl-37515937

Asunto(s)

Neoplasias; Humanos; Glutaratos; Ácidos Cetoglutáricos; Estereoisomerismo; Mutación; Microambiente Tumoral

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Curr Opin Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google